vs
Side-by-side financial comparison of C4 Therapeutics, Inc. (CCCC) and Cosmos Health Inc. (COSM). Click either name above to swap in a different company.
Cosmos Health Inc. is the larger business by last-quarter revenue ($19.7M vs $11.0M, roughly 1.8× C4 Therapeutics, Inc.). Cosmos Health Inc. runs the higher net margin — -51.5% vs -186.0%, a 134.5% gap on every dollar of revenue. On growth, C4 Therapeutics, Inc. posted the faster year-over-year revenue change (112.8% vs 38.5%). Over the past eight quarters, C4 Therapeutics, Inc.'s revenue compounded faster (90.4% CAGR vs 16.2%).
C4 Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing targeted protein degradation therapies for cancer and other severe diseases with high unmet medical needs. It leverages its proprietary TORPEDO platform to design small molecule degraders that eliminate disease-causing proteins, with a pipeline of oncology candidates in preclinical and clinical development, plus strategic partnerships with leading global pharmaceutical firms.
AgniKul Cosmos Private Limited is a private Indian aerospace manufacturer and commercial launch service provider based in National Centre for Combustion Research and Development (NCCRD) of IIT Madras, Chennai. The start up aims to develop and launch its own small-lift launch vehicle such as the Agnibaan, capable of placing 100 kg (220 lb) payload into a 700 km (430 mi) orbit.
CCCC vs COSM — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $11.0M | $19.7M |
| Net Profit | $-20.5M | $-10.1M |
| Gross Margin | — | 10.6% |
| Operating Margin | -210.1% | -57.9% |
| Net Margin | -186.0% | -51.5% |
| Revenue YoY | 112.8% | 38.5% |
| Net Profit YoY | 40.7% | -203.0% |
| EPS (diluted) | $-0.09 | $-0.33 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $11.0M | $19.7M | ||
| Q3 25 | $11.2M | $17.1M | ||
| Q2 25 | $6.5M | $14.7M | ||
| Q1 25 | $7.2M | $13.7M | ||
| Q4 24 | $5.2M | $14.2M | ||
| Q3 24 | $15.4M | $12.4M | ||
| Q2 24 | $12.0M | $13.2M | ||
| Q1 24 | $3.0M | $14.6M |
| Q4 25 | $-20.5M | $-10.1M | ||
| Q3 25 | $-32.2M | $-5.4M | ||
| Q2 25 | $-26.0M | $-2.8M | ||
| Q1 25 | $-26.3M | $-818.1K | ||
| Q4 24 | $-34.6M | $-3.3M | ||
| Q3 24 | $-24.7M | $-8.4M | ||
| Q2 24 | $-17.7M | $-2.6M | ||
| Q1 24 | $-28.4M | $-1.9M |
| Q4 25 | — | 10.6% | ||
| Q3 25 | — | 15.2% | ||
| Q2 25 | — | 7.9% | ||
| Q1 25 | — | 14.9% | ||
| Q4 24 | — | 7.1% | ||
| Q3 24 | — | 9.7% | ||
| Q2 24 | — | 5.8% | ||
| Q1 24 | — | 9.1% |
| Q4 25 | -210.1% | -57.9% | ||
| Q3 25 | -306.4% | -10.6% | ||
| Q2 25 | -441.0% | -17.9% | ||
| Q1 25 | -402.9% | -6.1% | ||
| Q4 24 | -728.4% | -63.0% | ||
| Q3 24 | -183.9% | -18.0% | ||
| Q2 24 | -178.6% | -18.9% | ||
| Q1 24 | -1060.2% | -12.6% |
| Q4 25 | -186.0% | -51.5% | ||
| Q3 25 | -286.4% | -31.3% | ||
| Q2 25 | -402.6% | -19.2% | ||
| Q1 25 | -363.7% | -6.0% | ||
| Q4 24 | -667.8% | -23.5% | ||
| Q3 24 | -160.6% | -67.5% | ||
| Q2 24 | -147.6% | -19.6% | ||
| Q1 24 | -933.2% | -12.8% |
| Q4 25 | $-0.09 | $-0.33 | ||
| Q3 25 | $-0.44 | $-0.17 | ||
| Q2 25 | $-0.37 | $-0.10 | ||
| Q1 25 | $-0.37 | $-0.03 | ||
| Q4 24 | $-0.50 | $-0.46 | ||
| Q3 24 | $-0.35 | $-0.45 | ||
| Q2 24 | $-0.26 | $-0.15 | ||
| Q1 24 | $-0.41 | $-0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $74.6M | $761.8K |
| Total DebtLower is stronger | — | $3.8M |
| Stockholders' EquityBook value | $256.6M | $18.4M |
| Total Assets | $359.1M | $65.5M |
| Debt / EquityLower = less leverage | — | 0.20× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $761.8K | ||
| Q3 25 | $58.8M | $922.6K | ||
| Q2 25 | $78.2M | $30.3K | ||
| Q1 25 | $51.3M | $25.3K | ||
| Q4 24 | $55.5M | $336.3K | ||
| Q3 24 | $59.6M | $22.8K | ||
| Q2 24 | $73.1M | $21.5K | ||
| Q1 24 | $89.7M | $21.3K |
| Q4 25 | — | $3.8M | ||
| Q3 25 | — | $5.4M | ||
| Q2 25 | — | $5.2M | ||
| Q1 25 | — | $4.9M | ||
| Q4 24 | — | $4.1M | ||
| Q3 24 | — | $4.3M | ||
| Q2 24 | — | $3.9M | ||
| Q1 24 | — | $4.1M |
| Q4 25 | $256.6M | $18.4M | ||
| Q3 25 | $154.4M | $23.1M | ||
| Q2 25 | $174.1M | $26.2M | ||
| Q1 25 | $195.1M | $26.0M | ||
| Q4 24 | $216.0M | $24.5M | ||
| Q3 24 | $242.7M | $35.0M | ||
| Q2 24 | $247.1M | $32.1M | ||
| Q1 24 | $258.3M | $34.5M |
| Q4 25 | $359.1M | $65.5M | ||
| Q3 25 | $265.5M | $69.5M | ||
| Q2 25 | $296.5M | $61.8M | ||
| Q1 25 | $319.5M | $57.2M | ||
| Q4 24 | $349.6M | $54.3M | ||
| Q3 24 | $376.1M | $64.5M | ||
| Q2 24 | $381.1M | $60.8M | ||
| Q1 24 | $398.4M | $62.3M |
| Q4 25 | — | 0.20× | ||
| Q3 25 | — | 0.23× | ||
| Q2 25 | — | 0.20× | ||
| Q1 25 | — | 0.19× | ||
| Q4 24 | — | 0.17× | ||
| Q3 24 | — | 0.12× | ||
| Q2 24 | — | 0.12× | ||
| Q1 24 | — | 0.12× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-22.1M | $-4.6M |
| Free Cash FlowOCF − Capex | — | $-4.6M |
| FCF MarginFCF / Revenue | — | -23.4% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-8.5M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-22.1M | $-4.6M | ||
| Q3 25 | $-31.2M | $-2.5M | ||
| Q2 25 | $-12.1M | $-1.2M | ||
| Q1 25 | $-33.3M | $-186.3K | ||
| Q4 24 | $-17.9M | $-3.8M | ||
| Q3 24 | $-24.1M | $739.8K | ||
| Q2 24 | $-5.0M | $-1.2M | ||
| Q1 24 | $-18.1M | $-3.4M |
| Q4 25 | — | $-4.6M | ||
| Q3 25 | $-31.6M | $-2.5M | ||
| Q2 25 | — | $-1.2M | ||
| Q1 25 | — | $-198.8K | ||
| Q4 24 | $-17.9M | $-3.9M | ||
| Q3 24 | $-24.1M | $511.0K | ||
| Q2 24 | $-5.2M | $-1.2M | ||
| Q1 24 | — | $-3.5M |
| Q4 25 | — | -23.4% | ||
| Q3 25 | -281.5% | -14.4% | ||
| Q2 25 | — | -8.4% | ||
| Q1 25 | — | -1.5% | ||
| Q4 24 | -346.5% | -27.5% | ||
| Q3 24 | -157.2% | 4.1% | ||
| Q2 24 | -43.1% | -9.4% | ||
| Q1 24 | — | -24.0% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | 3.7% | 0.1% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.1% | ||
| Q4 24 | 0.1% | 0.5% | ||
| Q3 24 | 0.1% | 1.8% | ||
| Q2 24 | 1.6% | 0.3% | ||
| Q1 24 | 0.0% | 0.6% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
